A 62-year-old retired account executive complains of diffuse chest pain with moderate activity. His hypercholesterolemia and hypertension have been well controlled. On treadmill testing, he fatigues at a heart rate of 140 bpm. You discuss the option of a pharmacological stress radionuclide study, but his reaction is concern. When questioned, he divulges that he and his wife had recently read an article in a popular lifestyle magazine that warned that "such tests cause cancer."
The concept of radiation, a physical entity that penetrates the human body yet defies perception, is emotionally laden and triggers archetypical angst in many. In recent years, a considerable number of alarmist reports have raised the specter of cancer risk from commonly prescribed imaging tests. [1] [2] [3] These publications have received widespread dissemination in the lay media, often in a sensationalist manner, so medical professionals are increasingly confronted by the above patient scenario and its many variations. Public concerns have prompted the US Food and Drug Administration to devote considerable attention to radiation protection, and some states have mandated reporting of radiation doses from imaging examinations. The purposes of this Clinician Update are to summarize the evidence on stochastic risks from diagnostic cardiovascular imaging tests involving ionizing radiation, to enable a realistic appraisal of risk, and to facilitate a rational dialog between healthcare providers and their patients.
Is There Direct Evidence of Cancer Risks From Imaging Tests Involving Ionizing Radiation?
Direct evidence for an association between radiation from medical imaging and cancer induction is exceedingly scarce. The most convincing evidence is derived from 2 recent, large, epidemiological studies in young, predominantly pediatric populations. 4, 5 Based on ≈10 year follow-up of 178 000 and 680 000 children and adolescents, respectively, these studies report an incremental risk of ≈2 to 6 excess cancers per 10 000 children and young adults from computed tomography (CT). Direct evidence of an association between radiation from medical imaging and cancer induction in a general adult population does not exist. Much larger cohorts would likely have to be analyzed to detect any incremental increases in cancer rates because ≈38% of women and 44% of men in the United States will develop cancer during their lifetime. 6
Cancer Risks From Imaging Tests: Estimates and Extrapolations
The overwhelming majority of recent reports on cancer risks from medical imaging are not based on actual epidemiological observations but are derived from extrapolation of risk estimates to low levels of radiation and multiplication with a large number of exposed individuals. Estimates of cancer risks from diagnostic imaging are most commonly based on the Biological Effects of Ionizing Radiation (BEIR VII) report. 7 Among experiences with other (eg, occupational) sources of radiation exposure, this report chiefly takes into account observations from the atomic bomb blasts in Hiroshima and Nagasaki that describe a statistically significant increase in cancer incidence in Japanese survivors exposed to radiation doses of ≥100 mSv. The BEIR VII report tabulates estimates for the lifetime attributable risk of cancer from exposure to this 100-mSv dose level. The reported confidence intervals are wide, allowing considerable variability in the extrapolation of risk toward the lower or higher limits of confidence. Diagnostic medical imaging procedures ordinarily are associated with radiation doses well below 100 mSv. The extrapolation of radiation risks to such low levels of radiation is problematic and subject to substantial uncertainties. These extrapolations are based on the hypothesis that cancer risk increases linearly with radiation dose (linear nothreshold model; Figure 1 ). For lack of better data, the linear no-threshold model currently represents a reasonable, conservative compromise and thus is commonly used in radiation protection policy. However, it remains uncertain whether this model accurately reflects the biological effect of low-level radiation and is suitable for prediction of cancer risks from medical imaging. 8
Radiation Dose Associated With Cardiovascular Imaging Tests
The effective dose values for diagnostic imaging tests ( Figure 2 ) are most meaningful compared with the annual background radiation from natural sources, which is ≈3 mSv in the United States. Figure 1 . Extrapolating cancer risks from atomic blasts to low radiation doses. There is evidence from atomic blast survivors for a linear relationship between radiation dose and cancer incidence above a radiation dose of 100 mSv (solid line). Various hypotheses for the extrapolation of radiation risk to lower radiation doses are shown as dotted lines.
The linear no-threshold model (1) is most widely used, but others have suggested that there may be a threshold dose below which radiation is harmless (2), protective (3), or disproportionately harmful (4). The imaging techniques used in clinical practice for suspected cardiovascular disease have undergone substantial technological improvements in recent years, which have markedly reduced the associated radiation dose. In cardiac CT, average radiation doses fell from 10 to 20 mSv to ≈3 mSv, 9 for example, by restricting the application of radiation to diagnostically meaningful cardiac phases. The radiation dose from CT for suspected pulmonary embolism was reduced from 15 mSv 10 to 2 to 5 mSv, 11 for example, by algorithms that automatically adapt the radiation output to the respective portion of the chest along the scanned anatomic volume. Single-photon-emission CT for myocardial perfusion imaging has seen similar reductions. In many situations, a low-dose 99m Tc-stress-only protocol provides sufficient diagnostic information at an effective dose of 3 mSv compared with the 22-mSv dose of a classic stress-rest dual-isotope protocol. 10, 12 The average radiation dose of cardiac 18 Fluorodeoxyglucose positron emission tomography has decreased from 14 mSv 10 to 5 mSv, 12 for example, by more stringent application of weight-based radiotracer dosing and more sensitive detector technologies.
Patients with cardiovascular disease frequently undergo repeated tests and procedures, and the cumulative radiation exposure has been estimated to average 16 mSv for a 3-year followup period and 64 mSv over a 20-year period. 13 When interpreting these numbers, one must consider that the effective dose is a useful measure to compare radiation dose between imaging modalities but is not intended to estimate the risk of a specific test in an individual patient. 14
Radiation Risks for Patients Undergoing Cardiovascular Imaging Examinations
When general estimations of radiation risks are applied to cardiovascular imaging examinations, both the characteristics of the patient population and the spectrum of cardiovascular diseases have to be considered. The majority of cardiovascular imaging tests are performed in adults >50 years of age. The potential harm from radiation in these individuals is substantially lower than in children and young adults because of both decreased vulnerability to radiation of mature tissues with increased age and a shorter life expectancy, allowing less time for cancers to manifest. Suspected or known coronary, cerebrovascular, or peripheral artery disease, pulmonary embolism, and aortic pathologies, all disorders with substantial morbidity and mortality, are among the most common indications for cardiovascular imaging tests. The radiation risks from these tests have to be weighed against the risks of missing or delaying the diagnosis of such conditions or inaccurately assessing their distribution or severity. Even in young patients, the risk of death resulting from underlying morbidity is more than an order of magnitude greater than the estimated risk of death resulting from long-term radiation-induced cancer. 15 Thus, this consideration is likely even more relevant in older patients with known or suspected cardiovascular disease. Cardiovascular imaging tests have excellent diagnostic accuracy for the detection of these pathologies, and effective therapeutic options exist. In the setting of an appropriate indication, not performing a cardiovascular imaging test places the patient at substantial risk by withholding the clinical benefits of imaging for guiding therapeutic management. Furthermore, the latency period for projections of radiationinduced malignancies can span several decades, whereas suspected cardiovascular disease regularly poses an imminent threat to the patient.
Comparison With Risks of Everyday Life
In discussions of radiation risks with patients, it can often be helpful to provide perspective vis-à-vis risks of everyday life. 16 The stochastic extrapolated lifetime risk of developing fatal cancer from radiation received during a cardiovascular imaging examination (0.05% or 1 in 2000) 17 is lower than the lifetime risk of drowning (1 in 1112) or dying in a pedestrian accident (1 in 749) and >10-fold lower than the lifetime risk of dying in a motor vehicle accident (1 in 108; Figure 3 ). Nevertheless, these everyday risks are commonly perceived as very low and 
Statements and Recommendation of Professional Associations
The American Association of Physicists in Medicine promulgated a professional statement urging that the discussion of risks related to radiation dose from medical imaging be accompanied by acknowledgment of the benefits of the procedures. 19 In keeping with the BEIR VII assumptions, the American Association of Physicists in Medicine considers risks of medical imaging at effective doses <50 mSv for single procedures or <100 mSv for multiple procedures over short time periods as too low to be epidemiologically detectable and potentially nonexistent. An almost identical position statement has been issued by the Health Physics Society. 20
Conclusions
Because of our uncertainties about the stochastic effects of radiation, it is reasonable to operate under the assumption that there is risk, however small. Accordingly, we should use all means at our disposal to keep radiation exposure as low as reasonably achievable without compromising the diagnostic information gained from the examination. Fear of radiation should not prevent a patient from undergoing a medically necessary imaging examination.
